Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00236899 | Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC | completed | Phase 3 | 241 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00376740 | Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole | completed | Phase 3 | 90 | Soroka University Medical CenterOTHER | 1 | Aug 23, 2011 | clinicaltrials |
| NCT00645138 | Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery | completed | Phase 3 | 40 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | completed | Phase 3 | 680 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | completed | Phase 3 | 1,300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00186212 | Alternative Support for Rural and Isolated Women in an HMO | completed | Phase 3 | 150 | Stanford UniversityOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00525096 | Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer | completed | Phase 3 | 157 | ARCAGY/ GINECO GROUPOTHER | 0 | Jun 30, 2011 | clinicaltrials |
| NCT00352378 | Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer | completed | Phase 3 | 209 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00294385 | Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine | completed | Phase 3 | 430 | Central European Cooperative Oncology GroupOTHER | 7 | Jun 23, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT00381901 | Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | completed | Phase 3 | 3,400 | National Cancer Institute, FranceOTHER_GOV | 1 | May 13, 2011 | clinicaltrials |
| NCT00193011 | Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer | completed | Phase 3 | 150 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT00236275 | PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer | completed | Phase 3 | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00016432 | Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen | completed | Phase 3 | 1,598 | NSABP Foundation IncNETWORK | 3 | Apr 19, 2011 | clinicaltrials |
| NCT00148876 | TBP Study With Capecitabine Plus Minus Trastuzumab | completed | Phase 3 | 482 | GBG Forschungs GmbHOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer(TAX316) | completed | Phase 3 | 1,491 | SanofiINDUSTRY | 20 | Feb 16, 2011 | clinicaltrials |
| NCT00327769 | Faslodex Advanced Breast Cancer Local Chinese Study | completed | Phase 3 | 234 | AstraZenecaINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT01267552 | Study of Axillary Lymphadenectomy Without Drainage for Breast Cancer | completed | Phase 2 / Phase 3 | 240 | Universidade Federal de GoiasOTHER | 1 | Dec 28, 2010 | clinicaltrials |
| NCT00078572 | Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer | completed | Phase 3 | 408 | GlaxoSmithKlineINDUSTRY | 0 | Dec 13, 2010 | clinicaltrials |
| NCT01108016 | Expanding Rural Access: Distance Delivery of Support Groups (Main Study) | completed | Phase 3 | 100 | Stanford UniversityOTHER | 1 | Dec 6, 2010 | clinicaltrials |
| NCT00524849 | Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis | completed | Phase 2 / Phase 3 | 60 | Fudan UniversityOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT00668616 | Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes | completed | Phase 3 | 1,034 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00607295 | Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients | completed | Phase 3 | 98 | Seoul National University HospitalOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00486473 | Multihance Versus Magnevist in Breast MRI(DETECT) | completed | Phase 3 | 130 | Bracco Diagnostics, IncINDUSTRY | 1 | Jul 15, 2010 | clinicaltrials |
| NCT00440089 | Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors | completed | Phase 2 / Phase 3 | 76 | University of California, San DiegoOTHER | 1 | May 25, 2010 | clinicaltrials |
| NCT00003972 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer | completed | Phase 3 | 280 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00314977 | Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.(INTENS) | completed | Phase 3 | 200 | Radboud University Medical CenterOTHER | 1 | Mar 18, 2010 | clinicaltrials |
| NCT00409071 | Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer. | completed | Phase 3 | 431 | Centre Leon BerardOTHER | 1 | Feb 5, 2010 | clinicaltrials |
| NCT00002707 | Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed | completed | Phase 3 | 2,411 | NSABP Foundation IncNETWORK | 2 | Feb 3, 2010 | clinicaltrials |
| NCT00232661 | PROACT - Pre-Operative Arimidex Compared To Tamoxifen | completed | Phase 3 | 452 | AstraZenecaINDUSTRY | 10 | Feb 3, 2010 | clinicaltrials |
| NCT00191152 | A Phase III Trial For Patients With Metastatic Breast Cancer | completed | Phase 3 | 475 | Eli Lilly and CompanyINDUSTRY | 8 | Dec 24, 2009 | clinicaltrials |
| NCT00333047 | Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy | completed | Phase 2 / Phase 3 | 24 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00146549 | Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer | completed | Phase 3 | 250 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00431106 | Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer | completed | Phase 3 | 144 | Hellenic Oncology Research GroupOTHER | 1 | Sep 28, 2009 | clinicaltrials |
| NCT00429871 | Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer | completed | Phase 3 | 272 | Hellenic Oncology Research GroupOTHER | 1 | May 29, 2009 | clinicaltrials |
| NCT00784862 | ATAC - Pharmacokinetics (PK) Sub-Protocol | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | May 15, 2009 | clinicaltrials |
| NCT00193908 | Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream | completed | Phase 3 | 333 | Trans Tasman Radiation Oncology GroupOTHER | 1 | May 14, 2009 | clinicaltrials |
| NCT00286117 | ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years | completed | Phase 3 | 448 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00814125 | ATAC - Endometrial Sub-Protocol | completed | Phase 3 | 285 | AstraZenecaINDUSTRY | 0 | May 1, 2009 | clinicaltrials |
| NCT00635713 | Second Line Breast Cancer Trial | completed | Phase 3 | 588 | AstraZenecaINDUSTRY | 0 | Apr 10, 2009 | clinicaltrials |
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00117910 | Treatment for Elderly Patients With High Risk Breast Cancer | completed | Phase 3 | — | AmgenINDUSTRY | 0 | May 16, 2008 | clinicaltrials |
| NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | completed | Phase 3 | 478 | Hellenic Oncology Research GroupOTHER | 1 | Jan 21, 2008 | clinicaltrials |
| NCT00201942 | PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | completed | Phase 3 | 336 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 18, 2007 | clinicaltrials |
| NCT00201929 | A Decision Aid for Women With Early Stage Breast Cancer | completed | Phase 3 | 300 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00114816 | Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer | completed | Phase 3 | 1,500 | Finnish Breast Cancer GroupOTHER | 1 | May 21, 2007 | clinicaltrials |
| NCT00161980 | Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites | completed | Phase 3 | — | Baxter Healthcare CorporationINDUSTRY | 4 | Oct 23, 2006 | clinicaltrials |
| NCT00359060 | Physical Activity and Breast Cancer Risk in Postmenopausal Women:the SHAPE Study | completed | Phase 3 | 180 | UMC UtrechtOTHER | 1 | Oct 13, 2006 | clinicaltrials |
| NCT00148057 | Diet and Breast Cancer Prevention Trial | completed | Phase 3 | 4,695 | University Health Network, TorontoOTHER | 1 | Sep 7, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Sep 27, 2011source: clinicaltrials